Navigating the NASH Maze
The availability of 2 approved medicines for the treatment of idiopathic pulmonary fibrosis (IPF) has stimulated an explosion in fibrosis…
TherapeutAix to present at ELRIG’s flagship conference, Drug Discovery
The European Laboratory Research & Innovation Group’s (ELRIG) flagship conference, Drug Discovery, is one of the largest meetings of life…
TherapeutAix present at The Society for Medicines Research meeting
The Society for Medicines Research (SMR) is holding a meeting on 26th September 2018 in Stevenage titled, ‘The Best of…
TherapeutAix are attending the European Respiratory Society (ERS), Paris, September 2018
TherapeutAix will be attending the ERS International Congress in Paris from Sunday 16th to Wednesday 19th September. We would love…
Four Pharma experts team up to launch new life sciences consultancy
Four colleagues, who previously worked together in the Innovative Medicines Unit (IMU) at Grünenthal, have combined their strategic and operational…
